COST-EFFECTIVENESS OF A SINGLE-INHALER TRIPLE THERAPY VS A DUAL BRONCHODILATOR FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN AUSTRALIA

被引：0
|
作者：
Schembri, S. [1 ]
Schroeder, M. [2 ]
Shah, D. [3 ]
Martin, A. [4 ]
Ndirangu, A. [3 ]
Risebrough, N. [3 ]
Thrasis, A. [5 ]
Bremner, P. [6 ]
Haberl, M. [5 ]
Ismaila, A. [7 ]
机构：
[1] Canberra Hosp, Dept Resp & Sleep Med, Garran, ACT, Australia
[2] GlaxoSmithKline, Value Evidence & Outcomes, Brentford, England
[3] ICON Hlth Econ, Dublin, Ireland
[4] GlaxoSmithKline, Value Evidence Analyt, Brentford, England
[5] GlaxoSmithKline, Reimbursement & Pricing, Brentford, England
[6] Univ Notre Dame, Sch Med, Resp Med, Notre Dame, IN 46556 USA
[7] GlaxoSmithKline, Value Evidence & Outcomes, Brentford, England
来源：
RESPIROLOGY | 2020年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
TP 071
引用
收藏
页码：145 / 145
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness of a single inhaler triple therapy versus ICS/LABA in COPD
    Martin, Alan A.
    Shah, Dhvani
    Goodall, Emma C.
    Schroeder, Melanie
    Risebrough, Nancy
    Ndirangu, Kerigo
    Ismaila, Afisi S.
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [32] Improving inhaler adherence in patients with Chronic Obstructive Pulmonary Disease: a cost-effectiveness analysis
    Job FM van Boven
    Eline Tommelein
    Koen Boussery
    Els Mehuys
    Stefan Vegter
    Guy GO Brusselle
    Maureen PMH Rutten-van Mölken
    Maarten J Postma
    Respiratory Research, 15
  • [33] Improving inhaler adherence in patients with Chronic Obstructive Pulmonary Disease: a cost-effectiveness analysis
    van Boven, Job F. M.
    Tommelein, Eline
    Boussery, Koen
    Mehuys, Els
    Vegter, Stefan
    Brusselle, Guy G. O.
    Rutten-van Molken, Maureen P. M. H.
    Postma, Maarten J.
    RESPIRATORY RESEARCH, 2014, 15
  • [34] Single-inhaler triple versus dual bronchodilator therapy for GOLD group E and other exacerbating patients with COPD: real-world comparative effectiveness and safety
    Suissa, Samy
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62 (03)
  • [35] INFORMING THE PATHWAY OF COPD TREATMENT (THE IMPACT STUDY): SINGLE INHALER TRIPLE THERAPY (FF/UMEC/ VI) VERSUS DUAL BRONCHODILATOR THERAPY (UMEC/ VI) IN PATIENTS WITH COPD - COST-EFFECTIVENESS IN THE UK
    Anley, G.
    Shah, D.
    Schroeder, M.
    Ndirangu, K.
    Risebrough, N.
    Okorogheye, G.
    Fenwick, E.
    Martin, A.
    Ismaila, A. S.
    THORAX, 2018, 73 : A236 - A237
  • [36] Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy: two replicate trials in patients with chronic obstructive pulmonary disease (COPD)
    Ferguson, G. T.
    Brown, N.
    Compton, C.
    Corbridge, T. C.
    Dorais, K.
    Fogarty, C.
    Harvey, C.
    Kaisermann, M. C.
    Lipson, D. A.
    Martin, N.
    Sciurba, F.
    Stiegler, M.
    Zhu, C. Q.
    Bernstein, D.
    PNEUMOLOGIE, 2021, 75 : S45 - S46
  • [37] Once-Daily Single-Inhaler Versus Twice-Daily Multiple-Inhaler Triple Therapy: Two Replicate Trials in Patients with Chronic Obstructive Pulmonary Disease (COPD)
    Ferguson, G. T.
    Brown, N.
    Compton, C.
    Corbridge, T. C.
    Dorais, K.
    Fogarty, C. M.
    Harvey, C.
    Kaisermann, M. C.
    Lipson, D. A.
    Martin, N.
    Sciurba, F. C.
    Stiegler, M. A.
    Zhu, C.
    Bernstein, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [38] Characteristics and treatment pathways of COPD patients initiating single-inhaler dual or triple therapy in England
    Noorduyn, Stephen G.
    Wood, Robert P.
    Rothnie, Kieran J.
    Rai, Kiran K.
    Seif, Monica
    Massey, Lucy
    Compton, Chris
    Ismaila, Afisi S.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [39] COST-EFFECTIVENESS OF SINGLE-INHALER EXTRAFINE BECLOMETHASONE DIPROPIONATE/FORMOTEROL FUMARATE/GLYCOPYRRONIUM VS OTHER OPEN OR SINGLE-INHALER TRIPLE THERAPIES IN ADULT PATIENTS WITH UNCONTROLLED ASTHMA IN ENGLAND
    Orlovic, M.
    Tzelis, D.
    Guerra, I
    Madoni, A.
    VALUE IN HEALTH, 2023, 26 (12) : S128 - S129
  • [40] ECONOMIC EVALUATION OF SINGLE INHALER TRIPLE THERAPY FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) USING THE GALAXY MODEL
    Risebrough, N.
    Schroeder, M.
    Shah, D.
    Goodall, E.
    Ndirangu, K.
    Martin, A.
    Ismaila, A.
    VALUE IN HEALTH, 2018, 21 : S414 - S414
12345